Skip to main content

Table 4 Standardised difference of confounding variables between TPV/PR and BOC/PR patients after the three approaches to matching

From: Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry

 

After naïve matching

After 0.1 caliper limit

After 0.2 caliper limit

Treatment experinced

0.000

0.04

0.04

Presence of cirrhosis

0.000

0.022

0.022

Age

−0.014

0.011

0.016

BMI

−0.003

−0.005

−0.002

Baseline HCV > 800,000

0.019

0.019

0.019

GT1

−0.022

0.000

0.000

GT1b

0.019

0.039

0.039

IL28B CT

0.018

−0.018

−0.018

IL28B TT

0.027

0.072

0.028